Abstract
Leptin is an adipocyte-derived hormone with pleiotropic effects on energy homeostasis, endocrine and reproductive functions, and immune responses. The multiple actions of leptin have led to the design and development of several leptin-based approaches to modulate the metabolic and endocrine status, to reduce inflammation, and to improve immune responses. Here, we review the current patents on leptin in different clinic applications.
Keywords: Leptin, metabolism, therapeutics
Recent Patents on Inflammation & Allergy Drug Discovery
Title: Leptin as Clinical Target
Volume: 3 Issue: 3
Author(s): Chunlin Cai, Fu-Dong Shi, Giuseppe Matarese and Antonio La Cava
Affiliation:
Keywords: Leptin, metabolism, therapeutics
Abstract: Leptin is an adipocyte-derived hormone with pleiotropic effects on energy homeostasis, endocrine and reproductive functions, and immune responses. The multiple actions of leptin have led to the design and development of several leptin-based approaches to modulate the metabolic and endocrine status, to reduce inflammation, and to improve immune responses. Here, we review the current patents on leptin in different clinic applications.
Export Options
About this article
Cite this article as:
Cai Chunlin, Shi Fu-Dong, Matarese Giuseppe and Cava La Antonio, Leptin as Clinical Target, Recent Patents on Inflammation & Allergy Drug Discovery 2009; 3 (3) . https://dx.doi.org/10.2174/187221309789257379
DOI https://dx.doi.org/10.2174/187221309789257379 |
Print ISSN 1872-213X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-2710 |
Related Articles
-
The Anti-Proliferative Effect of a Newly-Produced Anti-PSCA-Peptide Antibody by Multiple Bioinformatics Tools, on Prostate Cancer Cells
Recent Patents on Anti-Cancer Drug Discovery The Challenges of Modeling Drug Resistance to Antiangiogenic Therapy
Current Drug Targets Organoids: Current Implications and Pharmaceutical Applications in Liver Diseases
Current Molecular Pharmacology Immune Cells Act as Promising Targets for the Treatment of Bone Metastasis
Recent Patents on Anti-Cancer Drug Discovery PPARγ: Potential Therapeutic Target for Ailments Beyond Diabetes and its Natural Agonism
Current Drug Targets LncRNA HOTAIR Polymorphisms Association with Cancer Susceptibility in Different Tumor Types
Current Drug Targets The Heme Oxygenase/Biliverdin Reductase Pathway in Drug Research and Development
Current Drug Metabolism Fork Head Transcription Factors
Current Genomics The Pathogenesis of Lung Cancer and Chromosome 11
Current Genomics The Crosstalk of RAS with the TGF-β Family During Carcinoma Progression and its Implications for Targeted Cancer Therapy
Current Cancer Drug Targets Proteases as Anti-Cancer Targets - Molecular and Biological Basis for Development of Inhibitor-Like Drugs Against Cancer
Anti-Cancer Agents in Medicinal Chemistry New Generation of Oncolytic Herpes Virus
Current Cancer Therapy Reviews MicroRNA Dysregulation in the Myelodysplastic Syndromes
MicroRNA Recent Trends in Targeted Anticancer Prodrug and Conjugate Design
Current Medicinal Chemistry The Antimitotic Potential of PARP Inhibitors, An Unexplored Therapeutic Alternative
Current Topics in Medicinal Chemistry Functional Role of miR-34 Family in Human Cancer
Current Drug Targets Src Inhibitors and Angiogenesis
Current Pharmaceutical Design Unveiling the Role of Nuclear Transport in Epithelial-to-Mesenchymal Transition
Current Cancer Drug Targets Fanconi Anemia Proteins, DNA Interstrand Crosslink Repair Pathways, and Cancer Therapy
Current Cancer Drug Targets The Roles of Sox Family Genes in Sarcoma
Current Drug Targets